Skip to main navigation
Skip to search
Skip to main content
SAHMRI Home
Home
Profiles
Research units
Research output
Datasets
Prizes
Activities
Search by expertise, name or affiliation
New Directions in Leukaemia Research (NDLR)
Eadie, L.
(Participant)
Acute Lymphoblastic Leukaemia Group
Activity
:
Other
Description
Lagonik E, Page EC, Eadie LN, Forgione MO, Yeung DT, Hughes TP, White DL
Efficacy of asciminib against ABL2 fusion genes in the treatment of high-risk Ph-like Acute Lymphoblastic Leukaemia
Adelaide, Australia
Poster Presentation.
Period
4 Mar 2024
→
6 Mar 2024
Event title
New Directions in Leukaemia Research (NDLR)
Event type
Conference
Location
Adelaide, Australia, South Australia
Show on map
Degree of Recognition
National